DIE BEHANDLUNG OPIATSUECHTIGER MIT OPIATEN UND IHREN ANTAGONISTEN = TRAITEMENT DES OPIOMANES PAR LES OPIACES ET LEURS ANTAGONISTESBURCHARD JM.1972; NERVENARZT; DTSCH.; DA. 1972; VOL. 43; NO 10; PP. 501-504; BIBL. 15REF.Serial Issue

Administration de cyclazocine pour la neuroleptanalgésie modifiéeKUGIMIYA, T; HANAOKA, K; YAMAURA, H et al.Masui. 1983, Vol 32, Num 9, pp 1095-1103, issn 0021-4892Article

Effects of heroin, methadone, LAAM and cyclazocine on acquisition and performance of response sequences in monkeysMOERSCHBAECHER, J. M; THOMPSON, D. M; WINSAUER, P. J et al.Pharmacology, biochemistry and behavior. 1983, Vol 19, Num 4, pp 701-710, issn 0091-3057Article

A CONTROLLED COMPARISON OF CYCLAZOCINE AND NALOXONE TREATMENT OF THE PAROLED NARCOTIC ADDICTHANLON TE; MCCABE O; SAVAGE C et al.1975; INTERNATION. PHARMACOPSYCHIATRY; SWITZ.; DA. 1975; VOL. 10; NO 4; PP. 240-250; BIBL. 10 REF.Article

THE USE OF CYCLAZOCINE IN TREATING NARCOTIC ADDICTS IN A LOW-INTERVENTION SETTING = UTILISATION DE LA CYCLAZOCINE DANS LE TRAITEMENT DES TOXICOMANES AUX NARCOTIQUES DANS UN ETABLISSEMENT D'INTERVENTION PEU IMPORTANTKLEBER H; KINSELLA JK; RIORDAN C et al.1974; ARCH. GEN. PSYCHIATRY; U.S.A.; DA. 1974; VOL. 30; NO 1; PP. 37-42; BIBL. 14REF.Article

NARCOTIC ANTAGONISTS: A REASONABLE METHOD OF TREATING NARCOTIC DEPENDENCY = LES ANTOGONISTES DES STUPEFIANTS: UNE METHODE RAISONNABLE DE TRAITEMENT DE LA DEPENDANCE AUX STUPEFIANTSSCHOOFF KG; HERSCH RG; KEEGAN JF et al.1975; INTERNATION. J. ADDICT.; U.S.A.; DA. 1975; VOL. 10; NO 3; PP. 391-400; BIBL. 7 REF.Article

Phencyclidine-like effect of cyclazocine on pentylentetrazol-induced seizures in laboratory animalsSAGRATELLA, S; NIGLIO, T; ORTOLANI, E et al.Pharmacology, biochemistry and behavior. 1985, Vol 22, Num 4, pp 515-519, issn 0091-3057Article

PARTIAL AGONIST PROPERTIES AND TOXICITY OF ORAL OXILORPHANSELLERS EM; THAKUR R.1976; J. CLIN. PHARMACOL.; U.S.A.; DA. 1976; VOL. 16; NO 4; PP. 183-188; BIBL. 11 REF.Article

KAPPA OPIATE BINDING SITES IN HUMAN PLACENTAPORTHE G; VALETTE A; CROS J et al.1981; BIOCHEM. BIOPHYS. RES. COMMUN.; ISSN 0006-291X; USA; DA. 1981; VOL. 101; NO 1; PP. 1-6; BIBL. 9 REF.Article

ETUDE EXPERIMENTALE DE L'ACTION DIURETIQUE D'UN ANTAGONISTE DES MORPHINIQUES, LA CYCLAZOCINE.GAVEND M; GAVEND MR; SERRE F et al.1978; J. PHARMACOL.; FR.; DA. 1978; VOL. 9; NO 1; PP. 77-88; ABS. ANGL.; BIBL. 12 REF.Article

NEUROPHARMACOLOGICAL COMPARAISON OF CYCLAZOCINE AND IMIPRAMINEDREW WG; WHITE RP.1973; PHARMACOLOGY; SWITZ.; DA. 1973; VOL. 9; NO 2; PP. 65-73; BIBL. 14REF.Serial Issue

EVIDENCE THAT THE DISCRIMINATIVE STIMULUS PROPERTIES OF FENTANYL AND ETHYLKETOCYCLAZOCINE ARE MEDIATED BY AN INTERACTION WITH DIFFERENT OPIATE RECEPTORSSHEARMAN GT; HERZ A.1982; JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS; ISSN 0022-3565; USA; DA. 1982; VOL. 221; NO 3; PP. 735-739; BIBL. 35 REF.Article

AN INVESTIGATION OF THE NEGATIVE-REINFORCING PROPERTIES OF NALOXONE AND CYCLAZOCINE IN SQUIRREL MONKEYSSTRETCH R; PINK C; GERVAIZE P et al.1980; CANAD. J. PHYSIOL. PHARMACOL.; CAN; DA. 1980; VOL. 58; NO 4; PP. 384-391; BIBL. 11 REF.Article

EFFECTS OF MORPHINE, PENTAZOCINE AND CYCLAZOCINE ALONE AND IN COMBINATION WITH NALOXONE ON ELECTRIC SHOCK TITRATION IN THE SQUIRREL MONKEYDYKSTRA LA.1979; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1979; VOL. 211; NO 3; PP. 722-732; BIBL. 30 REF.Article

Cyclazocine revisitedARCHER, S; GLICK, S. D; BIDLACK, J. M et al.Neurochemical research. 1996, Vol 21, Num 11, pp 1369-1373, issn 0364-3190Article

Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 3: 8-Thiocarboxamido and 8-thioformamido derivatives of cyclazocineWENTLAND, Mark P; XUFENG SUN; YIGONG BU et al.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 10, pp 2547-2551, issn 0960-894X, 5 p.Article

A laboratory study of hydromorphone and cyclazocine on smoking behavior in residential polydrug usersPICKWORTH, Wallace B; LEE, Eun M; ABREU, Mary E et al.Pharmacology, biochemistry and behavior. 2004, Vol 77, Num 4, pp 711-715, issn 0091-3057, 5 p.Article

RADIOIMMUNOASSAY OF CYCLAZOCINE AND STEREOSPECIFICITY OF ANTIBODYMAEDA M; TSUJI A.1981; J. PHARMACOBIO-DYN.; ISSN 0386-846X; JPN; DA. 1981; VOL. 4; NO 3; PP. 167-174; BIBL. 15 REF.Article

IN VIVO AND IN VITRO EVALUATION OF A MICROENCAPSULATED NARCOTIC ANTAGONIST. = EVALUATION IN VIVO ET IN VITRO D'UN ANTAGONISTE DES STUPEFIANTS MICROENCAPSULEMASON N; THIES C; CICERO TJ et al.1976; J. PHARM. SCI.; U.S.A.; DA. 1976; VOL. 65; NO 6; PP. 847-850; BIBL. 5 REF.Article

EFFET DE LA CYCLAZOCINE SUR LA CIRCULATION CORONAIRE, LA CONTRACTILITE MYOCARDIQUE ET SON APPLICATION A L'ANESTHESIE GENERALENAKAMURA H; NIYA S; YUKINARI T et al.1982; MASUI; ISSN 0021-4892; JPN; DA. 1982; VOL. 31; NO 9; PP. 990-997; ABS. ENG; BIBL. 28 REF.Article

CYCLAZOCINE IN THE TREATMENT OF OPIATE ADDICTION: A REVIEW WITH RECOMMENDATIONSGOLDSTEIN MJ.1980; INT. J. ADDICT.; ISSN 0020-773X; USA; DA. 1980; VOL. 15; NO 7; PP. 939-956; BIBL. 1 P.Article

SOME EFFECTS OF PENTAZOCINE AND CYCLAZOCINE ON THE ISOLATED GUINEA-PIG ATRIA.KUCUKHUSEYIN C.1977; ARCH. INTERNATION. PHARMACODYN. THERAP.; BELG.; DA. 1977; VOL. 225; NO 1; PP. 114-123; BIBL. 24 REF.Article

In rats, acute morphine dependence results in antagonist-induced response suppression of intracranial self-stimulationEASTERLING, Keith W; HOLTZMAN, Stephen G.Psychopharmacologia. 2004, Vol 175, Num 3, pp 287-295, issn 0033-3158, 9 p.Article

Electrophysiological interactions of isomers of cyclazocine with the phencyclidine antagonist metaphit in rat cerebellar Purkinje neuronsYUN WANG; PALMER, M. R; FREEDMAN, R et al.The Journal of neuroscience. 1986, Vol 6, Num 11, pp 3189-3196, issn 0270-6474Article

ANALGESIC ACTION OF CYCLAZOCINE: BLOCKING NOCICEPTIVE RESPONSES INDUCED BY INTRA-ARTERIAL BRADYKININ-INJECTION AND TOOTH PULP STIMULATIONSATOH M; KAWAJIRI S; YAMAMOTO M et al.1979; ARCH. INTERNATION. PHARMACODYN. THERAP.; BEL; DA. 1979; VOL. 241; NO 2; PP. 300-306; BIBL. 10 REF.Article